Terrestar Solutions joins with Equatys, expanding shared satellite infrastructure for global direct-to-device and advanced MSS connectivity while preserving national sovereignty

 

OTTAWA, Ontario - Wednesday, 28. October 2026

• Space42 and Viasat, co-founders of Equatys, and Terrestar Solutions sign a memorandum of understanding to develop an open, standards-based interoperability framework between Equatys and Terrestar’s CaStar constellation 
• Each infrastructure operator would retain ownership and control of its own space and ground assets and customers, with CaStar operating as a sovereign Canadian system while interworking with Equatys globally
• The shared infrastructure framework combines nationally controlled assets with global shared satellite infrastructure, unlocking greater scale and economic benefits and enabling next-generation direct-to-device and advanced mobile satellite services for nations, enterprises, and consumers worldwide

 

 

(GLOBE NEWSWIRE) -- Space42 (ADX: SPACE42), the UAE-based AI-powered SpaceTech company, and Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite and secure communications, and Terrestar Solutions Inc., Canada's only sovereign mobile-satellite services operator, today signed a memorandum of understanding (MoU) to collaborate on developing an open, standards-based interoperability framework between Terrestar's planned Canadian low-Earth orbit (LEO) constellation, CaStar, and Equatys, a planned global shared infrastructure platform for direct-to-device (D2D) services and other advanced Mobile-Satellite Services (MSS). The MOU was signed on the sidelines of the official visit of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, United Arab Emirates, to Canada, where His Highness attended talks with the Right Honourable Mark Carney, Prime Minister of Canada.

The framework is intended to allow the two systems, together with their respective ground segments, to interwork as a coordinated multi-system non-terrestrial network (NTN) infrastructure, while each operator retains full ownership and control of its own assets. This approach is designed to enable global scale while preserving national sovereignty over critical communications infrastructure.

The MoU advances a partnership model that would combine Terrestar's position as a Canadian-controlled and Canadian-operated MSS provider with Equatys' role as a shared, multi-tenant, interoperable global infrastructure enabling D2D and advanced MSS services in a 5G network environment. The collaboration between Equatys’s founders and Terrestar is the first example of Equatys’s “sovereign shell” approach that combines a global commercial system with constellations optimized for specific countries or regions, each with their dedicated ground segment and run by a trusted local operator, built to common standards that keep them fully interoperable.

Rather than relying on proprietary, point-to-point integration, the parties intend to define a common, open, and standards-based interoperability layer. This approach is expected to foster collaboration, drive adoption, reduce capital and operational expenditures, and enable better coordination of power, beams, capacity, and ground gateway access among participating systems.

Today’s announcement comes after Space42 and Viasat signed a binding agreement in September 2026 to co-found Equatys, backed by up to USD 1 billion in combined equity commitments.

Speaking on the occasion, Karim Michel Sabbagh, Managing Director of Space42, said: "This MoU demonstrates how sovereign satellite systems and shared global infrastructure can work together to deliver D2D services globally. Terrestar maintains its position as Canada's independent MSS operator while exploring how to participate in a broader ecosystem. We are introducing a model where national capabilities and international collaboration reinforce rather than compete with one another."

Mark Dankberg, Chairman and CEO of Viasat, said: “By advancing a global, standards-based open architecture with an interoperability framework via a shared infrastructure model, we are continuing to expand an ecosystem that will be uniquely positioned to drive mass adoption within the significant D2D and next-generation MSS market. This collaboration with Terrestar underscores Equatys’ innovative approach to offer a foundation for choice and interoperability and provide compelling economic benefits from geographic and spectral efficiencies to participating global, regional, and national space operators. Equatys is committed to working across the global space industry, as well as with the broader ecosystem including MNOs, OEMs, chipset vendors, regulators and standards bodies.”

Jacques Leduc, President and CEO of Terrestar Solutions, said: “The future of mobile satellite connectivity won’t be built by countries or constellations acting alone. It will be built through open standards-based networks that combine national sovereignty with global reach, positioning us to compete at scale. While working hand-in-hand with the Canadian space ecosystem, CaStar is Canada’s contribution to that future: Canadian-controlled, globally connected, and built to work with other mid-power countries like Canada. We look forward to helping build a truly global network together with our partners at Space42 and Viasat. Terrestar’s ambition is to seamlessly integrate satellite and terrestrial mobile networks, bringing connectivity to everyday devices. Our goal is to make mobile satellite connectivity a reality for every Canadian, wherever they live, work, or travel around the world. This MoU is just the beginning.”

His Excellency Dr. Thani bin Ahmed Al Zeyoudi, Minister of Foreign Trade, said: “The UAE’s deepening trade and investment links with Canada, embodied in the newly signed Comprehensive Economic Partnership Agreement, are laying the foundations for long-term, mutually beneficial collaborations in critical sectors. The memorandum of understanding between Space42, Viasat and Terrestar Solutions is a clear example, bringing together companies from the UAE, the United States and Canada to develop shared, standards-based infrastructure for the next generation of satellite connectivity. Collaboration of this kind reflects the UAE’s vision of deeper economic integration, where partnership drives innovation that can cross borders, scale quickly and attract long-term capital.”

Partnership Framework

The MoU reflects a shift away from closed, single-operator satellite systems toward an open standards-based model, in which independent constellations can interwork as a coordinated multi-system NTN infrastructure. Under the proposed framework, the parties would define a common standardized interoperability layer linking their respective space and ground segments. This layer would rely on published, vendor-neutral interfaces aligned with 3GPP NTN specifications, GSMA roaming and interconnection frameworks, and other recognized industry standards, avoiding proprietary lock-in.

Each participating operator would retain control of its own space and ground assets, authorizations and customer relationships, interacting with other systems only through agreed interfaces. Within that boundary, each system would make defined resources and capabilities, such as power, beams and gateway access, available to the others, supported by common mechanisms for resource requests, allocation, monitoring, usage accounting and settlement.

The framework is also designed to respect national sovereignty and security. System infrastructure serving a given jurisdiction could be located and operated to meet local regulatory, security and lawful access requirements. In Canada, for example, the CaStar constellation would operate as a sovereign national system, with Canadian gateways and ground network keeping domestic data within Canadian jurisdiction, while interworking with Equatys at a global scale.

Finally, the framework is intended to be extensible, to accommodate additional satellite systems, mobile network operators and service providers over time, and evolve with successive releases of industry standards.

About Equatys
Equatys will be an independent, neutral shared space and ground infrastructure platform for direct-to-device and advanced mobile satellite services licensees, co-founded by Space42 and Viasat under a binding agreement backed by up to USD 1 billion in combined equity commitments. Operating on a Tower Company model, it is designed to deliver compelling economic and performance benefits to global, regional and national operators holding appropriate MSS and/or SCS licenses, and to enable choice, interoperability and economically attractive NTN access for ecosystem participants. As the user base expands through access to globally coordinated spectrum, Equatys seeks to deliver compounding growth and sustainable shareholder value. It is being built on 3GPP NTN standards.
For more information, visit www.equatys.com

About SPACE42

Space42 (ADX: SPACE42) is a UAE-based, AI-powered SpaceTech company that integrates satellite communications and geospatial intelligence to enlighten the Earth from space. It operates through two business units. Space Services runs a fleet of geostationary satellites, including the Thuraya mobile network, delivering secure connectivity across land, sea, and air in more than 120 countries. Smart Solutions operates a synthetic aperture radar constellation in low Earth orbit, covering 90% of the world’s population, and uses AI to turn that imagery into actionable insight. Space42 serves governments and enterprises across defense and security, energy, environmental conservation, and autonomous mobility. Major shareholders include G42, Mubadala and International Holding Company (IHC).
For more information, visit: space42.ai
LinkedIn: Space42ai
Instagram: Space42ai
X: Space42ai

About Viasat
Viasat is a global communications company that believes everyone and everything in the world can be connected. With offices in 24 countries around the world, our mission shapes how consumers, businesses, governments and militaries around the world communicate and connect. Viasat is developing the ultimate global communications network to power high-quality, reliable, secure, affordable, fast connections to positively impact people's lives anywhere they are—on the ground, in the air or at sea, while building a sustainable future in space. In May 2023, Viasat completed its acquisition of Inmarsat, combining the teams, technologies and resources of the two companies to create a new global communications partner. Learn more at www.viasat.com, the Viasat News Room or follow us on LinkedIn, X, Instagram, Facebook, Bluesky, Threads, and YouTube.

About Terrestar Solutions
Terrestar Solutions Inc. is the only Canadian-controlled mobile satellite operator engaged in the race to bring direct-to-device satellite services to smartphones and IoT devices and make anywhere-in-Canada communication a reality. Terrestar is committed to nurturing the ever-evolving, standards-based and open network ecosystem, enabling Mobile Network Operators to deliver ubiquitous communication services. Thanks to the Echostar T1 satellite,  its ground network infrastructure and 40 MHz of S-band mobile-satellite spectrum, Terrestar connects Canadians from almost anywhere in the country, even in Canada’s most remote regions, through its Strigo Mobile Satellite Service (MSS). The Strigo service also supports non-profit and First Nations organizations, a testament to the Company’s powerful sense of responsibility toward the welfare and progress of the communities it serves. Its upcoming CaStar low-Earth orbit (LEO) constellation will support the evolution of satellite services toward a cellular-like experience across Canada’s entire landmass. For more information, visit terrestarsolutions.ca or follow them on LinkedIn.

Media Contacts
Media.relations@equatys.com

Space42
media@space42.ai

Viasat
PR@viasat.com

Terrestar Solutions
Marie-Eve Francoeur
media@terrestar.ca

Legal Notice and Cautionary statement regarding forward-looking information

This announcement contains forward-looking statements based on current expectations and assumptions about future events that are subject to the safe harbors created under the Securities Act of 1933 and Securities Exchange Act of 1934. These statements—identified by terms such as "expect," "will," “anticipate,” “plan,” “designed,” “target” or similar—are subject to risks and uncertainties and may prove inaccurate. Forward-looking statements include, among others, statements that refer to the formation of Equatys; the timing and amount of the parties' respective equity contributions; the enabling of global D2D and advanced mobile satellite services, including the timing of commercial rollout; the procurement, design, manufacture, launch and deployment of Equatys' first-generation constellation and related ground network; the design, business model, features, performance and benefits of the Equatys platform; the investment framework, including expected benefits, risks and returns; the closing of definitive agreements, including the satisfaction of regulatory and other closing conditions; and plans, objectives and strategies for future operations. Readers are cautioned that actual results could differ materially from those expressed in any forward-looking statements. Factors that could cause actual results to differ include: risks and uncertainties related to the formation of Equatys and the closing of definitive agreements, including the failure to obtain required regulatory approvals; the failure to satisfy the closing conditions on a timely basis or at all; the parties’ ability to fund their respective equity commitments; risks associated with the construction, launch and operation of satellites, including the effect of any anomaly, launch, operational or deployment failure or degradation in satellite performance; changes in relationships with, or the financial condition of, key customers, suppliers or ecosystem partners; the ability to successfully develop, introduce and sell new technologies, products and services; increasing levels of competition in target markets; the ability for Equatys to successfully implement its business plan on the anticipated timeline or at all; regulatory risks; and other risks affecting the communications and D2D industries generally. In addition, please refer to the risk factors contained in Viasat’s SEC filings available at www.sec.gov, including Viasat’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. The parties undertake no obligation to revise or update any forward-looking statements for any reason.

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/ba97aa0a-966f-446f-9712-3e92618092ab
https://www.globenewswire.com/NewsRoom/AttachmentNg/5d62d71c-0bc0-44f9-82b9-9e1ec8b44d0f

Belkin Introduces Infinity Folio for iPad mini, Available Now

 LOS ANGELES -

With a precision-engineered hinge that allows flexible viewing angles, all-around drop protection, and a frosted translucent back panel, Infinity Folio is the perfect companion for iPad mini from day one

(BUSINESS WIRE) -- Belkin, a global leader in consumer electronics accessories trusted by more than 1 billion customers worldwide, today introduced Infinity Folio, a beautifully crafted protective case exclusively designed for iPad mini. The Infinity Folio is engineered to protect without compromise. A thin, lightweight and translucent back lets the new iPad mini design shine through with 360° of protection against drops of up to 2 meters*. The ingeniously engineered detachable cover transforms into a stand with multiple viewing angles. Whether it's streaming a favorite show, joining a video call, or reading an exciting book, Infinity Folio adapts to every moment. Designed specifically for iPad mini, Infinity Folio is available at launch through Apple stores and online in select markets worldwide, with additional retail availability by the end of the year.

Engineered for every angle

At the heart of Infinity Folio is its detachable cover, an elegant piece of engineering that takes the versatility of iPad mini to the next level. Belkin developed an easy-angle hinge with automatic magnetic snap that holds iPad mini steady at several viewing angles, each one designed for a different moment in the day. Upright positions are made for streaming a favorite series or joining a video call, and lower angles are made for typing, reading, or sketching. Every angle locks firmly into place with no slipping or wobbling. The cover attaches and detaches in seconds, so Infinity Folio goes from a protective case to a versatile stand whenever the moment calls for it. The hinge has been tested through more than 10,000 cycles to perform reliably day after day.**

Protection, beautifully clear

A frosted translucent back panel, crafted from premium polycarbonate, has a soft, refined finish that lets iPad mini's color shine through while guarding against everyday wear. Infinity Folio protects the device on every side, with drop protection of up to 2 meters (6.6 feet)*. Reinforced corners, made from durable thermoplastic polyurethane, absorb impact where it matters most, and raised edges help protect the display and camera. An anti-scratch finish resists scuffs and scratches, so Infinity Folio keeps looking polished, whether it's tossed in a bag, carried on a commute, or packed for travel. Precisely cut openings keep the buttons, ports, and camera easy to reach.

Smart, simple, seamless

Thoughtful details make each day with iPad mini effortless. A built-in magnetic closure puts the device to sleep automatically when the cover is closed and wakes it up the moment it's opened. That helps preserve battery life without an extra step, so it's easy to pick up right where you left off. The magnets also keep the cover securely closed when iPad mini is in transit.

Key features

Detachable cover that works as a stand

Flexible viewing angles, made possible by easy-angle kickstand

Frosted back that shows off the iPad mini design

Full protection on all sides

Drop protection up to 2 meters (6.6 ft)*

Durable anti-scratch finish

Magnetic cover that puts the device to sleep automatically

Apple Pencil slot for easy attachment, pairing and charging

Pricing and availability

Infinity Folio is available starting October 28th at Apple retail stores and apple.com in select markets with additional retail availability by the end of year. It comes in Charcoal and Lunar Rock and costs $79.95 USD. Availability may vary by market.

Media kit

Imagery is available for download HERE.

*Devices tested to survive when dropped at a height of up to 2m. Based on MIL-STD-810G standards, tested by independent 3rd party labs. Results may vary.

**Based on internal testing, hinge remains functional, with no tears, up to 10,000 bends. Actual results may vary.

About Belkin

Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261028098950/en/

Permalink

https://www.aetoswire.com/en/news/2910202658557

Contacts

Media contact

Jen Wei

VP of Marketing

comms@belkin.com

Sharjah Unveils Uruk: A New Generation of Sustainable Cities Built for the Post-AI Era

 Sharjah, United Arab Emirates - Thursday, 29. October 2026

In the presence of His Highness Sheikh Dr. Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, and Her Highness Sheikha Bodour bint Sultan Al Qasimi, President of American University of Sharjah and Chairperson of Sharjah Research, Technology and Innovation Park, a pioneering model for a new generation of cities designed for the post-AI era called “Uruk”.

The project was revealed at the opening of the second edition of Sharjah Next, through a strategic partnership between Sharjah Research, Technology and Innovation Park (SPARK), American University of Sharjah (AUS) and SEE Holding, bringing together their capabilities in innovation, scientific research and sustainable urban development.

Uruk introduces a new vision for urban living, harnessing artificial intelligence and resource independence to create abundance in resources and time, enhancing quality of life and wellbeing.

Designed to achieve self-sufficiency and produce all its energy from solar, wind and biogas, the city will also integrate groundwater desalination, treated water reuse and circular waste management. Indoor and outdoor farming, fish, eggs and honey production, and private farming plots for residents will support local food production, complemented by suppliers across Sharjah.

Hussain Al Mahmoudi, CEO of SPARK, said: “Our ambition is to create an AI-powered innovation city, where technology is embedded into its foundations from the outset. A city where researchers work alongside entrepreneurs, global companies collaborate with universities, ideas are tested in real-world settings, and innovations move faster from the laboratory into society.”

Faris Saeed, Founder and Chairman of SEE Holding, said: “The true measure of progress is not what technology can achieve, but what it makes possible for people. When a city produces its essential resources, manages them intelligently and eases everyday demands, it gives residents something invaluable: more time for family, creativity, health and community life.”

Uruk will deploy robotics and intelligent systems to support everyday services, including deliveries, cleaning and security, reducing routine demands on residents. Its urban design will prioritize walking and cycling, alongside electric and shared mobility solutions.

The city will also function as a living laboratory for research and innovation, enabling researchers, students and entrepreneurs to develop and test emerging technologies in real-world conditions, with residents actively participating in shaping solutions that address community needs and accelerate their application.

Permalink

https://www.aetoswire.com/en/news/29102026

Contacts

Joyce Mourad

media@seeholding.com

Transition Industries Signs Definitive EPC Agreement with Siemens Energy and Techint E&C for Pacifico Mexinol’s 210 MW Electrolyzer Facility

 MEXICO CITY -

Definitive agreement advances delivery of the electrolyzer facility supplying renewable hydrogen for ultra-low-carbon methanol production in Sinaloa, Mexico

(BUSINESS WIRE) -- Transition Industries LLC today announced that it has signed a definitive Engineering, Procurement and Construction (EPC) agreement with Siemens Energy and Techint Engineering & Construction (“Techint E&C”) for the approximately 210 MW electrolyzer facility at its Pacifico Mexinol project in Sinaloa, Mexico. The agreement is subject to customary conditions precedent, including the completion of project financing.

The signing builds on the Front-End Engineering Design (FEED) contract announced in August 2025 and represents an important milestone in advancing the project’s renewable hydrogen production infrastructure from engineering toward construction.

The facility will incorporate Siemens Energy’s Elyzer P-300 electrolyzer technology and produce renewable hydrogen to support the production of renewable fuels of non-biological origin (RFNBO) within Pacifico Mexinol’s planned 6,130-metric-ton-per-day ultra-low-carbon methanol complex. The technology plays a crucial role in achieving the project’s goals of efficiency, sustainability, and scalability.

“Moving from front-end engineering to a signed EPC agreement is a significant milestone for Pacifico Mexinol,” said Rommel Gallo, CEO of Transition Industries, the parent company of Pacifico Mexinol. “This agreement brings together Siemens Energy’s electrolysis technology and Techint’s construction capabilities to deliver a critical component of our project and a landmark for renewable hydrogen in the Americas. It reflects our continued commitment to developing world-scale infrastructure that can meet growing demand for lower-carbon fuels and chemical products.”

The EPC agreement establishes the next phase of collaboration among Transition Industries, Techint E&C and Siemens Energy, translating the facility’s engineering design into an integrated framework for delivery. Construction is expected to begin in early 2027, subject to satisfaction of the conditions precedent.

“At approximately 210 MW, this hydrogen plant would be Siemens Energy’s largest electrolyzer installation in the Americas. The project has the potential to accelerate low-carbon fuel production in the region and advance the global decarbonization of hard-to-abate industries,” said Dan Restrepo, Head of Electrolyzer Sales Americas.

“We are pleased to continue supporting Pacifico Mexinol in the development of the Project through our alliance with Siemens Energy. We will execute this work with the highest standards of safety, integrity and transparency, and with respect for the communities and the environment where we operate, contributing to the development of sustainable energy in Mexico”, said Esteban Trouet, Operations Sr. Director for Techint Engineering & Construction- North Region.

Once operational in 2030, Pacifico Mexinol is poised to be the largest standalone ultra-low carbon chemical production facility in the world, The facility will produce annually approximately 175,000 metric tons of RFNBO methanol, 175,000 metric tons of Recycled Carbon Fuel (RCF) methanol and 1.8 million metric tons of ultra-low carbon methanol from natural gas with carbon capture, helping meet growing global demand through a lower-carbon production model.

About Transition Industries

Transition Industries LLC, based in Houston, Texas, is a developer of world-scale, net-zero carbon methanol and hydrogen projects in North America. For more information about Pacifico Mexinol or Transition Industries, please email inquiries@transitionind.com

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261028748894/en/

Permalink

https://www.aetoswire.com/en/news/2910202658560

Contacts

Media Contacts:

Karin Nunan

Global Head of Corporate Affairs

knunan@transitionind.com

 

Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones

 

OSAKA, Japan - 

ORZEYFULTM approved in the U.S., Japan and China for narcolepsy type 1 (NT1), MIMRYLOTM launched in the U.S. for erythrocytosis in polycythemia vera (PV)

Zasocitinib advances to U.S. Food & Drug Administration (FDA) Priority Review and European Medicines Agency (EMA) review

Late-stage pipeline continues to advance

FY2026 full-year outlook upgraded to reflect foreign exchange (FX) benefit

Takeda will host a Capital Markets Day on Dec. 11, 2026, in Tokyo, Japan

 

(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) announced financial results for the first half of fiscal year 2026 (April 1, 2026, to Sept. 30, 2026). The period included the approval of ORZEYFUL (oveporexton) in the U.S., Japan and China, the U.S. launch of MIMRYLO (rusfertide), progress in the regulatory review of zasocitinib, and additional clinical evidence across the late-stage pipeline. Takeda’s focus remains on execution against the first horizon of its growth strategy: successfully launching three new medicines, advancing its late-stage pipeline, ensuring resilience of core in-line brands and executing its transformation program.

FY2026 First-Half Highlights

Revenue increased by 8.4% versus the prior period on an actual exchange rates (AER) basis and decreased by 1.0% at constant exchange rates (CER).

Core Operating Profit increased by 11.2% on an AER basis, and increased by 0.7% on a CER basis, supported by enterprise-wide transformation, which is helping fund growth investments.

Reported Operating Profit increased by 60.4% on an AER basis reflecting the end of the amortization period for VYVANSE® intangible assets and lower impairment charges.

Core EPS was 308 JPY, an increase of 10.5% at AER and decrease of 1.2% at CER. Reported EPS was 193 JPY, an increase of 169.0% at AER.

Adjusted Free Cash Flow was JPY 325.7 billion.

ORZEYFUL’s approvals in the U.S., Japan and China, together with the U.S. launch of MIMRYLO, mark significant progress toward Takeda’s near-term commercial priorities. ORZEYFUL is now available in Japan and China; its U.S. launch remains subject to Drug Enforcement Administration (DEA) scheduling.

MIMRYLO launched in the U.S. in August 2026 and is now available to patients.

The FDA accepted the New Drug Application (NDA) under Priority Review for zasocitinib; the EMA is also reviewing the application. Phase 3 head-to-head data in plaque psoriasis further strengthened the clinical evidence for zasocitinib.

FY2026 full-year outlook upgraded to reflect FX benefit.

Takeda President and Chief Executive Officer, Julie Kim, commented:

“The launches of ORZEYFUL and MIMRYLO, combined with the acceptance of zasocitinib under Priority Review and its positive head-to-head Phase 3 data, represent a significant moment for Takeda and reflect strong execution against our two-horizon growth strategy.”

“Our focus now is to translate these milestones into strong commercial execution, while continuing to advance our late-stage pipeline, ensuring resilience of our core in-line brands and unlocking capabilities through transformation. Progress against our priorities in Horizon One of our strategy is building the foundation for Takeda’s next phase of growth. We look forward to sharing more details on our growth strategy and how we will build sustainable leadership in our core therapeutic areas at our Capital Markets Day in December.”

Takeda Chief Financial Officer, Milano Furuta, commented:

“We are reinvesting transformation savings to support new product launches and advance our pipeline. Our first-half results demonstrate that we are on track in advancing our Horizon One priorities and we will continue our disciplined execution to deliver on our revised full-year forecast and management guidance.”

FINANCIAL HIGHLIGHTS for First-Half Results ended September 30, 2026

(Billion yen, except percentages and per share amounts)

Item

FY2026 H1

(Billion JPY)

FY2025 H1

(Billion JPY)

YoY (AER)

Revenue

2,407.0

2,219.5

+8.4%

Operating Profit

406.7

253.6

+60.4%

Margin

16.9%

11.4%

+5.5pp

Net Profit

305.6

112.4

+171.8%

EPS (Yen)

193

72

+169.0%

Operating Cash Flow

431.9

593.7

-27.2%

Adjusted Free Cash Flow (Non-IFRS)

325.7

525.4

-38.0%

Core (Non-IFRS) 

(Billion yen, except percentages and per share amounts)

Item

FY2026 H1

FY2025 H1

YoY (AER)

YoY (CER)

Revenue

2,407.0

2,219.5

+8.4%

-1.0%

Operating Profit

710.6

639.2

+11.2%

+0.7%

Margin

29.5%

28.8%

+0.7pp

 

Net Profit

489.6

438.6

+11.6%

-0.2%

EPS (Yen)

308

279

+10.5%

-1.2%

FY2026 Full-year Forecast and Guidance 

Takeda raised its FY2026 outlook mainly due to FX benefit. 

  

(Billion yen, except percentages and per share amounts)

Item

FY2026 ORIGINAL MANAGEMENT GUIDANCE

AT CER

(MAY 2026)

FY2026 REVISED

MANAGEMENT GUIDANCE

AT CER

(OCT 2026)

Core Revenue

Low-single digit % decline

Low-single digit % decline

Core Operating Profit

5% to 8% decline

Mid-single digit % decline

Core EPS (Yen)

Mid-teens % decline

Low-teens % decline

Item

FY2026

ORIGINAL FORECAST

(MAY 2026)

FY2026

REVISED FORECAST

(OCT 2026)

Revenue

4,640.0

4,700.0

Core Revenue (Non-IFRS)

4,640.0

4,700.0

Operating Profit

420.0

453.0

Core Operating Profit (Non-IFRS)

1,160.0

1,190.0

Net Profit

166.0

209.0

EPS (Yen)

104

131

Core EPS (Yen) (Non-IFRS)

472

482

Adjusted Free Cash Flow (Non-IFRS)

650.0 – 750.0

700.0-800.0

Annual dividend per share (Yen)

204

204

New Medicines and Late-Stage Pipeline Progress

New medicine approvals and late-stage pipeline progress during the first half of FY2026 reinforce progress against Takeda’s strategic priorities. The following updates highlight key milestones.

ORZEYFUL

An orexin receptor agonist with a first-in-class mechanism of action, designed to address the orexin deficiency that causes narcolepsy type 1 (NT1).

Launched in Japan and China for adults with NT1 on October 15; U.S. commercial launch remains subject to DEA scheduling, expected in early November 2026.

Phase 3 results were published in the New England Journal of Medicine, demonstrating significant improvements across key symptoms and quality-of-life measures.

MIMRYLO

First-in-class hepcidin mimetic approved in the U.S. for the treatment of erythrocytosis in adults with polycythemia vera (PV); launched in August.

MIMRYLO has been shown to maintain hematocrit control, the primary treatment goal in PV, as well as reduce phlebotomy burden and alleviate symptoms including fatigue.

Approval supported by Phase 3 VERIFY results showing 76.9% of patients achieved clinical response during weeks 20-32.

MIMRYLO is the only treatment to be recommended as a Category 1 option across low- and high-risk PV in the National Comprehensive Cancer Network® (NCCN®) clinical practice guidelines in oncology for myeloproliferative neoplasms.

Zasocitinib

The FDA accepted the NDA under Priority Review for adults with moderate-to-severe plaque psoriasis; the EMA also accepted the Marketing Authorization Application for review.

Phase 3 demonstrated superiority to deucravacitinib on the primary and all key secondary efficacy endpoints; more than 2.5 times as many patients achieved complete skin clearance.

Zasocitinib remains investigational, with commercial launch planning underway, subject to regulatory approval.

Broader Oncology Pipeline

At the European Society for Medical Oncology (ESMO), Takeda presented positive Phase 3 results showing that arcotatug tavatecan (TAK-921) delivered statistically significant and clinically meaningful improvements in overall survival and progression-free survival in patients with advanced gastric cancer.

The findings support a regulatory filing in Japan in FY2027 and continued global development of arcotatug tavatecan in CLDN18.2-positive cancers.

Development of TAK-928 continues, including through a global Phase 3 study in patients with immunotherapy-resistant squamous NSCLC. Takeda also recently announced that it will expand this study to include a new sub-trial for patients with non-squamous NSCLC.

ELAHERE® (mirvetuximab soravtansine) was approved in Japan for folate receptor alpha-positive, platinum-resistant recurrent ovarian cancer.

Transformation, Capital Allocation and Shareholder Returns

Takeda continues to make solid progress on its enterprise transformation, a key FY2026 priority alongside the launch of new medicines and the advancement of its R&D pipeline. These efforts are designed to enhance operational efficiency, strengthen capabilities and optimize resource allocation, and support near-term execution under Horizon One of Takeda’s two-horizon growth strategy, while laying the foundation for sustainable growth under Horizon Two. Takeda maintains a disciplined capital allocation framework that prioritizes investment in new product launches and innovation, while maintaining its commitment to shareholder returns through its progressive dividend policy.

Additional Information Regarding FY2026 First Half Results

Takeda will host a conference call for investors and analysts on Thursday, Oct. 29, 2026, at 19:00 Japan Time / 6:00 U.S. Eastern Time to discuss its FY2026 first half results.

A live webcast of the conference call and the presentation materials will be available in the Investor Relations section of Takeda’s website (www.takeda.com/investors). The presentation materials include details on Takeda’s FY2026 first half results, business progress and pipeline updates, as well as definitions of non-IFRS measures.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit https://www.takeda.com.

Important Notice

For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this press release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

The product names appearing in this document are trademarks or registered trademarks owned by Takeda, or their respective owners.

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects”, “forecasts”, “outlook” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States and with respect to international trade relations; competitive pressures and developments; changes to applicable laws and regulations, including drug pricing, tax, tariff and other trade-related rules; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic; the success of our environmental sustainability efforts, in enabling us to reduce our greenhouse gas emissions or meet our other environmental goals; the extent to which our efforts to increase efficiency, productivity or cost-savings, such as the integration of digital technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings-and-security-reports/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

Financial information and Non-IFRS Measures

Takeda’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

This press release and materials distributed in connection with this press release include certain financial measures not presented in accordance with IFRS, such as Core Revenue, Core Operating Profit, Core Net Profit for the year attributable to owners of the Company, Core EPS, Constant Exchange Rate (“CER”) change, Net Debt, Adjusted Net Debt, EBITDA, Adjusted EBITDA, Free Cash Flow and Adjusted Free Cash Flow. Takeda’s management evaluates results and makes operating and investment decisions using both IFRS and non-IFRS measures included in this press release. These non-IFRS measures exclude certain income, cost and cash flow items which are included in, or are calculated differently from, the most closely comparable measures presented in accordance with IFRS. Takeda’s non-IFRS measures are not prepared in accordance with IFRS and such non-IFRS measures should be considered a supplement to, and not a substitute for, measures prepared in accordance with IFRS (which we sometimes refer to as “reported” measures). Investors are encouraged to review the definitions and reconciliations of non-IFRS measures to their most directly comparable IFRS measures, which are in the Financial Appendix appearing at the end of our FY2026 H1 investor presentation (available at www.takeda.com/investors).

Medical Information

This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261026300481/en/

Permalink

https://aetoswire.com/en/news/54629351

Contacts

Investor Relations

Christopher O’Reilly

Takeda.ir.contact@takeda.com

Media Relations

Corporate Communications

toiawase_kouhou@takeda.co.jp (Tokyo)

media_relations@takeda.com (Boston)

 

REV Ocean Appoints Paul Baribault as CEO Ahead of 2027 Global Operations

 Global conservation and philanthropic leader to spearhead REV Ocean's next chapter, connecting world-class science with international collaboration and ocean protection

 

(BUSINESS WIRE)--REV Ocean has appointed Paul Baribault as Chief Executive Officer as the organization moves towards the international debut of its 195-metre research vessel in Rio de Janeiro in April 2027, alongside the UN Ocean Decade Conference.

One of the world's largest privately owned research and exploration vessels, REV represents a major philanthropic investment in ocean science. With nine laboratories, advanced deep-sea exploration vehicles and dedicated collaboration facilities, it is designed to give scientists access to world-class research infrastructure and connect their discoveries with the people and institutions able to drive ocean protection.

Baribault joins as REV Ocean moves from a decade of engineering and construction into international operations. His mandate will be to build the international partnerships, funding base and organization needed to turn REV Ocean’s scientific capabilities into lasting ocean impact.

An experienced conservation and nonprofit leader, Baribault served as President and CEO of San Diego Zoo Wildlife Alliance from 2019 to 2025, expanding its global conservation programs and partnerships. Previously, he held senior roles at The Walt Disney Studios, including General Manager of Disneynature, where he developed conservation initiatives supporting habitat protection and restoration. He has also served as Chair of the Jane Goodall Institute.

Paul Baribault, incoming CEO of REV Ocean, said: “REV Ocean represents an extraordinary opportunity to change what is possible for ocean science and conservation. By giving scientists access to world-class technology and connecting their discoveries with those who can act, we can turn knowledge into meaningful progress. I look forward to building on the remarkable work already underway and expanding REV Ocean's international reach and impact.”

Kjell Inge Røkke, founder of REV Ocean, said: “REV Ocean was built to create something that did not exist. Paul understands what it takes to build organizations, bring people together and turn ambition into results. His experience across business, media and conservation makes him the right person to lead REV Ocean into its next chapter.”

Karen Simon, Executive Chair of REV Ocean, said: “Paul brings the leadership experience, conservation credentials and international perspective needed for this next chapter. Our focus is now on building the partnerships and institutional strength that will enable REV Ocean to deliver lasting impact. He will play a central role in that work, alongside Silje and the wider REV Ocean team.”

At the heart of REV Ocean's mission is a commitment to making advanced ocean science more accessible. The organization plans to provide selected scientific teams with access to the vessel, specialist equipment and experienced crew without charging for vessel time, subject to scientific selection and operational requirements.

REV's first ten philanthropic science missions, beginning in 2027, are planned with partners across the South Atlantic, Caribbean and Eastern Tropical Pacific. They will address urgent challenges including marine protected areas, plastic pollution and strengthening regional scientific capacity, helping connect research with conservation decisions.

Under the leadership of Chief Operating Officer and former Interim CEO Silje Ulvestad, REV Ocean's international team has overseen preparations for the vessel's transition into operation, including the testing of scientific systems, crew readiness and collaboration with research partners.

About REV Ocean

REV Ocean is a philanthropic ocean science organization dedicated to protecting and restoring the ocean. Its 195-metre research and exploration vessel is one of the world's largest privately owned vessels of its kind, designed to connect scientific discovery with real-world action.

REV Ocean focuses on four priorities: marine protected areas, marine plastic pollution, training the next generation of ocean scientists, and ocean literacy for decision-makers. Through advanced research infrastructure, open data and international collaboration, REV Ocean aims to close the gap between discovery and protection — for one healthy ocean.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261029204478/en/

Permalink

https://www.aetoswire.com/en/news/54631209

Contacts

Press contact: REVOcean@zenogroup.com

 

LeBron James Deepens Commitment to WHOOP, Expanding 11-Year Relationship

BOSTON - Thursday, 29. October 2026

One of the first 100 WHOOP members, James strengthens his commitment to the human performance company as the two partner to advance the future of performance, health, and longevity.

(BUSINESS WIRE) -- WHOOP, the human performance brand, today announced that basketball legend LeBron James has joined as a global ambassador, formalizing a relationship that began more than a decade ago. One of the company's earliest members and now an investor, James will partner with WHOOP to champion the importance of sustained athletic excellence and everyday vitality.

James began wearing WHOOP in 2015, long before continuous health monitoring became mainstream. Today, on the 23rd anniversary of his NBA debut, the 41-year-old continues to compete at the highest level of professional basketball. His decision to formalize the partnership reflects an 11-year relationship rooted in a shared commitment to performance, recovery, and longevity.

The expanded partnership brings together one of the world's most accomplished athletes and a company helping people take greater control of how they feel, perform, and age. Together, James and WHOOP will launch global initiatives and multimedia campaigns designed to inspire everyday athletes and consumers to invest in their body's future.

“LeBron James represents the pinnacle of performance and longevity,” said Will Ahmed, Founder and CEO of WHOOP. “He was one of the first 100 WHOOP members long before anyone had ever heard of Strain or our Recovery Score. Now, 11 years later, we’re so proud to have him as a global ambassador.”

James's commitment comes as WHOOP continues to expand beyond its roots in elite sport into personal health. Today, WHOOP serves more than 3 million members worldwide through an always-on membership that helps people understand their bodies, make better decisions, and invest in their long-term health. With continuous physiological monitoring, personalized insights, and innovations including WHOOP Age, the company is advancing its mission to unlock and inspire performance for life.

For James, the partnership reflects a philosophy that has defined his career: extraordinary performance is built through the decisions made every day, over years and decades. His commitment to training, sleep, recovery, and understanding his body has helped shape his approach to competing at the highest level into his 40s.

“I've spent my career doing everything possible to keep my body at peak performance. For the last 11 years, WHOOP has been part of that,” said LeBron James. "I know my body better today than I did at 25. I'm not trying to be great for my age. I'm trying to be great, period. That's why making this partnership official feels like a natural next step.”

That commitment is reflected in James's approach to sleep and recovery. Newly released WHOOP insights offer a glimpse into the daily habits behind his extraordinary longevity:

Top 10% of Sleepers: LeBron ranks among the top 10% on sleep efficiency across the entire WHOOP member base, demonstrating his exceptional commitment to sleep and recovery.

100% Wear Rate: LeBron has not missed a single day of WHOOP data collection in 2026, maintaining a perfect 100% wear rate throughout the year.

Sleep is Part of the Game Plan: Most known for his sleep and nap consistency, entering his 40s was no different: on his 40th birthday, James recorded 9+ hours of sleep, getting a 80%+ Green recovery.

The partnership will come to life through global marketing campaigns, content, and activations across WHOOP channels.

About WHOOP

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.

Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $950 million in venture capital, ships to 56 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261029868502/en/

Permalink

https://www.aetoswire.com/en/news/2910202658622

Contacts

Media Contact

Jack Taylor Worldwide

whoop@jacktaylorpr.com